Albion Financial Group Exact Sciences Corp Transaction History
Albion Financial Group
- $1.38 Billion
- Q1 2025
A detailed history of Albion Financial Group transactions in Exact Sciences Corp stock. As of the latest transaction made, Albion Financial Group holds 185 shares of EXAS stock, worth $10,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
185
Previous 185
-0.0%
Holding current value
$10,145
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding EXAS
# of Institutions
644Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$978 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$967 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$686 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$662 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$363 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.7B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...